SCHEMBL5570816

SCHEMBL5570816

CN(C(=O)CN1CCCC1)c1ccc(NC(=O)C(NC(=O)Nc2ccc(Cl)cc2)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.51
EP300 Q09472 2/20 0.45
UTS2R Q9UKP6 2/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 2/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43
CASR P41180 1/20 0.42
CNR1 P21554 1/20 0.42
CACNA2D1 P54289 1/20 0.42
CACNA1B Q00975 1/20 0.42
CACNB1 Q02641 1/20 0.42
CACNA1C Q13936 1/20 0.42
HRH3 Q9Y5N1 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CCKBR P32239 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570387 0.88 F10 (0.41) DRD4EP300UTS2RMAPTNPC1
SCHEMBL5570942 0.81 F10 (0.46) DRD4HRH3ALDH1A1
SCHEMBL6376149 0.79 MEN1 (0.59) UTS2RMAPTNPC1RAB9ACASR
SCHEMBL6376157 0.79 MEN1 (0.59) UTS2RMAPTNPC1RAB9ACASR
SCHEMBL5565619 0.78 CNR1 (0.51) EP300MAPTCASRCNR1HRH3
SCHEMBL6375747 0.77 ALDH1A1 (0.64) EP300MAPTNPC1TP53RAB9A
SCHEMBL6375742 0.77 ALDH1A1 (0.64) EP300MAPTNPC1TP53RAB9A
SCHEMBL8264405 0.75 ALDH1A1 (0.47) EP300MAPTNPC1RAB9ACNR1
SCHEMBL5570302 0.74 SLC6A2 (0.48) EP300UTS2RMAPTCASRCNR1
SCHEMBL5570567 0.73 CNR1 (0.52) EP300UTS2RMAPTCASRCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 WO disclosed